ArticleTechnology in cancer research & treatment

Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin Versus Sorafenib for Hepatocellular Carcinoma Refractory to Transarterial Chemoembolization: Retrospective Subgroup Analysis of 2 Prospective Trials.

YeXing Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.